Current Edition

The Elements Requiring Particular Attention while Conducting Clinical Trials in a Paediatric Population

Children account for 20-40% of the global population depending on the region, but only a third of all medications are officially approved to treat children. Maxim Belotserkovsky, Iryna Teslenko and Maxim Kosov of PSI CRO AG outline and review the elements to which particular attention should be paid when planning and conducting paediatric clinical trials.